Asthma treatment

http://www.healasthma.com past six monthsthe past twelve months Search Hint Connecting terms with AND narrows your search to give more precise results …more on search operators – . SHORT OF BREATH ASTHMA OFTEN TREATED WITH ‘RESCUE’ DRUGS, BUT DOCTORS FOCUS ON LONG-TERM SOLUTIONS Chris Gyves has never worried that his asthma might kill him. His deadly allergy to peanuts evokes far more fear than his asthma ever has.But the severe allergy attack that struck him one night last year made him realize that he needed more help for his allergies than he was getting. Now, he inhales steroids twice a day to help keep his asthma under control.Asthma is a disease associated with an ongoing inflammation of the breathing tubes. When an asthma attack occurs, the tubes and… . (New Jersey) – SCHERING-PLOUGH ISSUES RECALL ON ASTHMA INHALERS Schering-Plough Corp. is recalling some of its prescription asthma inhalers because they not contain active drugs, the pharmaceutical maker said Wednesday.The recall includes the Proventil and Warrick brands of inhalation aerosols, generic albuterol inhalers, and various doses of Vanceril inhalers made from Sept. to Sept. , .The company said it identified manufacturing problems as the cause.Asthma patients using the Proventil or Warrick brand of albuterol… Schering-Plough recalls some asthma inhalers NEW YORK – Schering-Plough Corp. said Wednesday it is recalling some of its prescription asthma inhalers because they not contain active drugs. The recall includes the Proventil and Warrick brands of inhalation aerosols, generic albuterol inhalers, and various doses of Vanceril inhalers made from Sept. to Sept. , . The company said it identified manufacturing problems as the cause.Asthma patients who are using their Proventil or Warrick brand of albuterol inhalers… . ASTHMA DRUG SHOWS PROMISE Adding another medicine to the traditional two-drug treatment for severe childhood asthma attacks substantially reduces the need to hospitalize sufferers, a study found. Researchers examined the effect of adding ipratropium bromide to the standard emergency room therapy for asthma attacks, albuterol and steroids. The result was a percent drop in the need for hospitalization, according to the study in today’s New England Journal of Medicine. … . Times, The (London, England) – Medeva asthma deal in US MEDEVA, the pharmaceutical group, has been given exclusive rights in America and Canada to sell two asthma drugs in a new type of CFC-free inhaler. The dry powder, multi-dose inhaler, trademarked Pulvinal, and the asthma drugs, salbutamol (albuterol) and beclomethasone, are being developed by Chiesi Farmaceutici, an Italian company.The drugs are about to enter the final stage of clinical trials in the US. Medeva said incidence of asthma was rising and the US market was worth … . NEW ASTHMA DRUG LASTS LONGER, IS MORE EFFECTIVE, STUDY FINDS CHICAGO — A new asthma inhalant drug works better at preventing attacks and lasts longer than a widely used medication, researchers say.The new drug, salmeterol xinafoate, was recently approved for marketing in the United States under the brand name Serevent.Researchers reporting in yesterday’s issue of The Journal of the American Medical Association compared the drug’s effectiveness with albuterol and a placebo among asthmatics ages and up…. . The Arizona Daily Star – New asthma drug is effective, report says A new asthma inhalant drug works better at preventing attacks and lasts longer than a widely used medication, researchers say.The new drug, salmeterol xinafoate, was recently approved for marketing in the United States under the brand name Serevent.Researchers reporting in yesterday’s issue of The Journal of the American Medical Association compared the drug’s effectiveness with albuterol and a placebo among asthmatics ages and up.Albuterol is a… . (New Jersey) – STUDY SAYS NEW DRUG IS EFFECTIVE FOR ASTHMA A new asthma inhalant drug works better at preventing attacks and lasts longer than a widely used medication, researchers say.The new drug, salmeterol xinafoate, was recently approved for marketing in the United States under the brand name Serevent.Researchers reporting in Wednesday’s issue of The Journal of the American Medical Association compared the drug’s effectiveness with albuterol and a placebo among asthmatics ages and up.Albuterol is a… . Copley blames bacteria for tainting drug Copley Pharmaceutical Inc. yesterday pinned the blame for contamination of an asthma drug on bacteria that grew in a damp machine, according to published reports. Officials at the Canton-based company were unavailable to confirm or comment on the report published in the Patriot Ledger.The apparent explanation would be the first to come from the company since the recall of Albuterol was announced Jan. , setting off a devastating wave of negative publicity about the maker of generic… . The Atlanta Journal and The Atlanta Constitution – Nation in Brief Drug firm recalls inhalation solution A Massachusetts generic drug company said Wednesday it is recalling millions of vials of an inhalation solution widely used by asthma patients and others with breathing problems. Copley Pharmaceutical Inc. said some of its -milliliter Albuterol Sulfate Inhalation Solution was contaminated by microbial organisms. It poses special risks of serious infection to people with compromised immune systems, including those with AIDS, cystic fibrosis, chronic obstructive lung disease and cancer… –